Browsing Tag
Food and Drug Administration
31 posts
H2 Global Group enters growth phase with hydrogen therapy for Alzheimer’s and neurodegenerative diseases
H2 Global Group eyes EU and FDA milestones as it advances hydrogen therapy for Alzheimer’s and projects $48M revenues by 2029—read the in-depth analysis.
Apiject seeks FDA approval for prefilled single-dose injection device using blow-fill-seal technology
Apiject files for FDA approval of its BFS-based prefilled injection device, aiming to cut costs, reduce foreign reliance, and reshape global drug delivery.
Mifepristone under fire: RFK Jr. orders FDA review of abortion pill used in most U.S. procedures
RFK Jr. orders FDA review of mifepristone, the abortion pill used in two-thirds of U.S. abortions. Explore the stakes for access, politics, and regulatory integrity.
Supreme Court says retailers can sue FDA over vape bans, citing NCLA in key ruling
Find out how the U.S. Supreme Court’s FDA vape ban ruling secures court access for retailers and cites the New Civil Liberties Alliance's amicus brief.
Booster drop-off alarms health officials as NB.1.8.1 and LP.8.1 variants gain ground
WHO flags sharp global drop in COVID-19 booster uptake amid rising NB.1.8.1 and LP.8.1 variants; CDC, India, U.K. ramp up fall vaccination planning.
Fall 2025 COVID booster update: FDA endorses JN.1-based vaccine as dominant LP.8.1 strain spreads
FDA backs fall 2025 COVID booster targeting LP.8.1; rollout to begin by August. New vaccine expected to offer stronger protection against dominant variants.
NB.1.8.1 variant monitored by WHO as global spread accelerates in May 2025
NB.1.8.1 spreads across U.S., India, and China in May 2025; WHO designates as Variant Under Monitoring. No rise in severity reported yet.
COVID-19 still killing 300 Americans weekly in 2025: Low vaccine uptake blamed
More than 300 Americans still die from COVID weekly. Find out why vaccine uptake, variant risks, and treatment gaps keep the toll high in 2025.
Co-Diagnostics revamps COVID-19 test for FDA clearance amid stability concerns
Co-Diagnostics, Inc. has announced that it is withdrawing its 510(k) clearance application for its Co-Dx PCR COVID-19 test…
Shocking mix-up in tortilla strips puts millions with wheat allergies at risk
Sugar Foods Corporation has announced a recall of its Fresh Gourmet Tortilla Strips Santa Fe Style, citing concerns…